About Cochlear
Cochlear is a company based in Mumbai (India) founded in 1981. The company has 5,500 employees as of June 30, 2025. Cochlear has completed 1 acquisition, including Sycle. Cochlear offers products and services including Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program. Cochlear operates in a competitive market with competitors including Advanced Bionics, Zhejiang Norcong Neuroelectronics, Esteem Hearing, Oticon Medical and Hemideina, among others.
- Headquarter Mumbai, India
- Employees 5500 as on 30 Jun, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cochlear Limited
-
Annual Revenue
$1.56 B (USD)4.32as on Jun 30, 2025
-
Net Profit
$256.97 M (USD)9as on Jun 30, 2025
-
EBITDA
$396.19 M (USD)-1.12as on Jun 30, 2025
-
Latest Funding Round
$537.22 M (USD), Post-IPO
Mar 28, 2020
-
Investors
European Union
& 1 more
-
Employee Count
5500
as on Jun 30, 2025
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cochlear
Cochlear is a publicly listed company on the ASX with ticker symbol COH in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cochlear
Cochlear offers a comprehensive portfolio of products and services, including Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program.
Smallest behind-the-ear processor for enhanced hearing support.
Discreet off-the-ear device for lightweight hearing assistance.
Free program offering resources and support for hearing implant users.
People of Cochlear
Unlock access to complete
Software Development Team
141 people
Sales and Marketing
108 people
Leadership Team
71 people
Product Management Team
42 people
Senior Team
42 people
Legal and Compliance
20 people
Area Team
14 people
Data Analysis and Operations Team
13 people
Unlock access to complete
Funding Insights of Cochlear
Investors in Cochlear
Cochlear has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Investor Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Cochlear
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cochlear
Cochlear has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sycle.
Investment portfolio details for Cochlear
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides software for audiology clinic management, patient care, and business efficiency.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Cochlear
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cochlear
Detailed financials for Cochlear
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cochlear Comparisons
Peer comparison for Cochlear
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cochlear
Cochlear operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Bionics, Zhejiang Norcong Neuroelectronics, Esteem Hearing, Oticon Medical and Hemideina, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of advanced cochlear implants and hearing technology for powerful connections
|
|
| Locked | Locked | Locked |
Multi-channel cochlear implants and speech processors are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of implanted hearing devices
|
|
| Locked | Locked | Locked |
Develops medical devices for cochlear implants and bone conduction hearing aids.
|
|
| Locked | Locked | Locked |
Cochlear implants for deafness treatment are developed.
|
|
| Locked | Locked | Locked |
Cochlear Implant
|
Detailed competitors of Cochlear
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cochlear
Complete news archive for Cochlear
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cochlear
Cochlear was founded in 1981 and raised its 1st funding round 18 years after it was founded.
Cochlear is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Dig Howitt is the current CEO of Cochlear.
As of Jun 30, 2025, the latest employee count at Cochlear is 5,500.
Annual revenue of Cochlear is $1.56B as on Jun 30, 2025.
Founded in 1981 and headquartered in Mumbai, India, Cochlear operates in the medical device sector, focusing on electronic hearing solutions. Cochlear implants are provided for individuals with moderate to profound hearing loss, while Baha bone conduction implants address conductive hearing loss, mixed hearing loss, and single-sided deafness. Acoustic implant solutions are also offered. The company acquired Entific in 2005 to expand its portfolio. Leadership is provided by CEO Dig Howitt.
Cochlear's top competitors include Advanced Bionics, Hemideina and Zhejiang Norcong Neuroelectronics.
Cochlear offers Nucleus 8 Sound Processor, Osia 2(I) Sound Processor, and Cochlear Family Program.
Yes, Cochlear is publicly traded on ASX under the ticker symbol COH.
Cochlear has made 1 acquisition, including Sycle.
Cochlear has 2 investors. Key investors include European Union, and Investor Growth Capital.
The ticker symbol of Cochlear is COH on ASX.